Mrskoš A., Kozák L., Pospíšilová J., Kamarýt J.:
|
191 |
Hutyra M.1, Novotný D.2, Halenka M.1, Karásek D.1, Vaverková, H.1:
The Relationship of
OxidizedLowDensity Lipoproteins (ox-LDL) to Carotid Artery Intima-Media Thickness
(IMT) and Other Biochemical and Clinical Risk Factor of Atherosclerosis
|
195 |
Novotný D.1, Hutyra M.2, Vaverková H.2:
Oxidized Low Density Lipoproteins: Significance
and Determination
|
200 |
Neumann D., Bukač J.1, Voříšek V.2, Pozler O., Bureš J.3:
Assessment of Gastric Emptying
by 13C-octanoic Acid Breath Test. Mathematical Analysis of Elimination: Moment Method
of Incomplete Gamma Function Estimation
|
206 |
Přistoupilová K., Přistoupil T. I.:
Systematization of Vitamins Derived from their Coordinated
Cooperation
|
215 |
Krajčovičová-Kudláčková M.1, Blažíček P.2, Spustová V.1:
Iron, Vitamin B12, Folic Acid
Levels and Haematological Parameters from Nutritional Aspect
|
226 |
Dastych M.1, Dastych M. jr.2, Malášková L.1, Chmelík, J.3, Čáslavský J.3:
The Risk of
Interference by HPLC Assay of 5-Hydroxyindole-3-acetic Acid in Patients Treated with
Aminosalicylates
|
231 |
Dastych M.1, Dastych M. jr.2, Sojková V.1, Malášková L.1:
Modification of HPLC Assay for
5-hydroxyindoleaceticAcid Estimationin Urine Resolved the Interference inTreatment
with 5-aminosalicylic Acid
|
235 |
Jabor A.1,2, Friedecký B.3, Hornová L.4, Břešťan D.1, Fischlová D.4:
Cystatin C. Part 2.
|
238 |
Friedecký B.1, Jabor A.2,3, Břešťan D.2, Hornová L.4, Fischlová D.4:
Cystatin C. Part 3.
|
243 |
Kazda A., Jabor A.:
Metabolic Alkalosis
|
249 |
Tichý M.1, Urban P.2, Matěja F.1, Hrnčíř Z.1, Plíšková L.3, Mraček J.4:
Laboratory Analysis of
a Series of 3049 Monoclonal Immunoglobulins
|
257 |
Stopka P.1, Křížová J.1, Navrátilová E.2:
Free Radicals in Human Hairs
|
262 |
